Patanjali's Coronil, 1st 'proof-based' drug to fight Covid, gets govt nod

Yoga guru Ramdev on Friday released a research paper by Haridwar-based Patanjali Research Institute on the "first evidence-based ayurvedic medicine" against the coronavirus disease, Coronil. Ramdev's Patanjali had last year brought out its medicine against Covid-19. Union health minister Harsh Vardhan and Union transport minister Nitin Gadkari were also present at the event.

Coronil has now received certification from Ayush Ministry as per World Health Organization (WHO) certification scheme.

"Coronil has received the Certificate of Pharmaceutical Product (CoPP) from the Ayush section of Central Drugs Standard Control Organisation as per the WHO certification scheme," said Patanjali in a statement.

Under CoPP, Coronil can now be exported to 158 countries.

Commenting of the development Ramdev said, Coronil will help the humanity while providing affordable treatment based on naturopathy.

On the basis of presented data, the Ministry of Ayush has recognised Coronil Tablet as a medicine for "supporting measure in Covid-19."

 

Controversy around Patanjali's Coronil
 

Ramdev-led Patanjali Ayurved had launched 'Coronil', for treating Covid-19 on June 23. Patanjali Chief Executive Officer (CEO) Acharya Balkrishna claimed that the medicine could cure Covid-19 patients within 5-14 days.
 

At the time of the launch of the medicine, the claim had been scoffed at by the AYUSH Ministry, which had asked the company to stop advertisements for the drug until the issue had been examined. The AYUSH ministry had also sought a detailed report on composition, testing and other data for the drug. The Centre had barred the firm from advertising the products after Ramdev said they cured 280 patients within days in trials. Coronil was then passed as "Immuno-booster" only.